Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.48 USD | +4.18% | +10.02% | +39.78% |
May. 09 | Pluri Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
May. 02 | Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment | CI |
Financials (USD)
Sales 2022 | 234K | Sales 2023 | 287K | Capitalization | 32.98M |
---|---|---|---|---|---|
Net income 2022 | -41M | Net income 2023 | -28M | EV / Sales 2022 | 58 x |
Net cash position 2022 | 26.21M | Net cash position 2023 | 10.27M | EV / Sales 2023 | 79.1 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-1.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.12% |
1 day | +4.18% | ||
1 week | +10.02% | ||
Current month | +15.72% | ||
1 month | +12.70% | ||
3 months | +8.49% | ||
6 months | +28.49% | ||
Current year | +39.78% |
Managers | Title | Age | Since |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 06-10-31 |
Director of Finance/CFO | 40 | 13-04-30 | |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 21-07-14 | |
Lorne Abony
BRD | Director/Board Member | 55 | 23-07-10 |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 6.48 | +4.18% | 13,413 |
24-05-13 | 6.22 | +6.96% | 12,115 |
24-05-10 | 5.815 | -2.43% | 3,501 |
24-05-09 | 5.96 | +1.53% | 6,263 |
24-05-08 | 5.87 | -0.34% | 4,652 |
Delayed Quote Nasdaq, May 14, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+39.78% | 34.92M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+46.96% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- PLUR Stock